| Metric | შპს ფარმაქსი | სს მეგა-ლაბი |
|---|---|---|
| Growth | ||
| Revenue | ₾37.2m₾38.4m | ₾18.4m₾20.4m |
| Revenue growth | -2.9% | -9.8% |
| Profitability | ||
| EBITDA | ₾2.3m₾4.9m | ₾936k-₾393k |
| EBITDA margin | 6.1%12.8% | 5.1%-1.9% |
| Net profit | ₾188k₾5.6m | -₾1.2m-₾2.6m |
| Net margin | 0.5%14.6% | -6.4%-12.7% |
| Balance sheet | ||
| Total assets | ₾53.9m₾85.6m | ₾27.8m₾25.4m |
| Total equity | ₾17.6m₾28.0m | ₾15.5m₾16.4m |
| ROE | 1.1%20.0% | -7.5%-15.8% |